小剂量多巴胺治疗新生儿窒息后肾损害的临床疗效观察被引量：3

下载PDF

导出

摘要目的观察小剂量多巴胺治疗新生儿窒息后肾损害的临床疗效。方法选取2013年1月—2014年12月我院收治的54例新生儿窒息后肾损害患儿为研究对象,将其随机分为观察组与对照组,对照组患儿给予常规治疗,观察组患儿给予常规治疗+小剂量多巴胺治疗。对比观察2组患儿的临床治疗效果。结果观察组总有效率为96.3%,对照组总有效率为74.1%,2组患者总有效率比较差异有统计学意义(P<0.05);治疗前,2组患儿血尿氮素(BUN)、肌酐(Cr)比较,差异不显著(P>0.05);治疗后,观察组患儿BUN、Cr等指标均低于对照组,差异有统计学意义(P<0.05)。结论小剂量多巴胺治疗新生儿窒息后肾损害的临床疗效显著,具有较高的临床推广价值。

作者赵静

机构地区社旗县妇幼保健院

出处《基层医学论坛》 2016年第6期757-758,共2页 The Medical Forum

关键词新生儿窒息肾损害多巴胺小剂量

分类号 R722.12 [医药卫生—儿科]

引文网络
相关文献

参考文献4

1靖芳,李芳君.脐血神经生长因子及新生儿行为神经评分与新生儿窒息的相关性研究[J].中国全科医学,2012,15(12):1335-1338. 被引量：24
2彭磊,乐功芳,龚益明.小剂量多巴胺治疗重度窒息新生儿肾功能损害的临床疗效[J].检验医学与临床,2014,11(23):3340-3341. 被引量：11
3方明俊,张薇,俞全胜,朱光华.血清胱抑素C检测对新生儿窒息患儿肾功能评估的临床意义[J].临床儿科杂志,2010,28(8):752-754. 被引量：22
4赵瑞卿,王新科.多巴胺联合多巴酚丁胺治疗新生儿窒息后肾损害的临床观察[J].中国妇幼保健,2013,28(3):452-454. 被引量：20

二级参考文献46

1BaoXiu-lan,YuRen-jie,LiZhuo-suan(Department of Pediairics. Peking Unton Medical coliege Hospitol, Beijing 100730.).应用20项新生儿行为神经测定预测窒息儿的预后[J].中华儿科杂志,1994,32(4):210-212. 被引量：114
2Stevens LA,Zhang Y,Sehmid CH.Evaluating the performance of equations for estimating glomerular filtration rate[J].J Nephrol,2008,21(6):797-807.
3Hojs R,Bevc S,Ekart R,et al.Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease[J].Ren Fail,2008,30(2):181-186.
4Larsson A,Akerstedt T,Hanssen LO,et al.Circadian variability of cystatin C,creatinine,and glomemlar filtration rate(GFR)in healthy men during normal sleep and after an acute shift of sleep[J].Chronobiol Int,2008,25(6):1047-1061.
5Chew JS,Saleem M,Florkowski CM,et al.Cystatin C-a paradigm of evidence based laboratory medicine[J].Clin Biochem Rev,2008,29(2):47-62.
6Martin MV,Barroso S,Herraez O,et al.Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease[J].Nefrologia,2006,26(4):433-438.
7Yashiro M,Kamata T,Segawa H,et al.Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease[J].Clin Exp Nephrol,2009,13(6):498-604.
8Sato H,Kuroda T,Tanabe N,et al.Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patient with rheumatoid and secondary amloidosis[J].Stand J Rheunatol,2010,39(1):33-37.
9Armangil D,Yurdakok M,Canpolat FE,et al.Determination of reference values for plasma eystatin and comparison with creatinine in premature infants[J].Pediatr Nephrol,2008,23(11):2081-2083.
10Andersen TB,Eskild-Jenden A,Frokiaer J,et al.Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review[J].Pediatr Nephrol,2009,24(5):929-941.